Showing results (71-80 of 347) with videos related to
Sort By:
Pageof 35
Transplantation|April 23, 2009
Minimizing the risk of chronic allograft nephropathyMatthew R Weir, Ravinder K WaliSub-Cellular Biochemistry|July 7, 2007
COX-2 inhibitors and cardiovascular riskDaniel J Salzberg, Matthew R WeirCurrent Hypertension Reports|August 13, 2010
Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease?Michael R Lattanzio, Matthew R WeirClinical Therapeutics|January 27, 2009
Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trialAndrew J Lewin, Matthew R WeirCurrent Opinion in Nephrology and Hypertension|March 28, 2014
Safety of medical therapy in patients with chronic kidney disease and end-stage renal diseaseMatthew R Weir, Jeffrey C FinkNature Reviews. Nephrology|May 16, 2012
Role of dietary therapies in the prevention and treatment of hypertensionViresh Mohanlal, Afshin Parsa, Matthew R WeirCurrent Hypertension Reports|May 2, 2003
Optimizing target-organ protection in patients with diabetes mellitus: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers?Wei X Lu, Jay Lakkis, Matthew R WeirCurrent Hypertension Reports|September 2, 2003
RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal diseaseJay Lakkis, Wei X Lu, Matthew R WeirNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2025
Treatment of diabetes in patients with advanced chronic kidney disease or kidney failureGeorge Bonifant, Stephen N Davis, Matthew R WeirKidney International|October 9, 2014
Cardiovascular risk assessment in kidney transplantationAllyson Hart, Matthew R Weir, Bertram L KasiskePageof 35